1,3-dimethyl-2-((2-oxopropyl)thio)imidazolium and Parkinson Disease

1,3-dimethyl-2-((2-oxopropyl)thio)imidazolium has been researched along with Parkinson Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beck, KE; Billett, EE; De Girolamo, LA; Griffin, M	1

Other Studies

1 other study(ies) available for 1,3-dimethyl-2-((2-oxopropyl)thio)imidazolium and Parkinson Disease

Article	Year
The role of tissue transglutaminase in 1-methyl-4-phenylpyridinium (MPP+)-induced toxicity in differentiated human SH-SY5Y neuroblastoma cells. Neuroscience letters, 2006, Sep-11, Volume: 405, Issue:1-2 Topics: 1-Methyl-4-phenylpyridinium; Cell Differentiation; Cell Line, Tumor; Cell Survival; GTP-Binding Proteins; Humans; Imidazoles; Neuroblastoma; Parkinson Disease; Polyamines; Protein Glutamine gamma Glutamyltransferase 2; Putrescine; Transglutaminases	2006

Article

Year

The role of tissue transglutaminase in 1-methyl-4-phenylpyridinium (MPP+)-induced toxicity in differentiated human SH-SY5Y neuroblastoma cells.

Neuroscience letters, 2006, Sep-11, Volume: 405, Issue:1-2

Topics: 1-Methyl-4-phenylpyridinium; Cell Differentiation; Cell Line, Tumor; Cell Survival; GTP-Binding Proteins; Humans; Imidazoles; Neuroblastoma; Parkinson Disease; Polyamines; Protein Glutamine gamma Glutamyltransferase 2; Putrescine; Transglutaminases

2006